MAPT and Alzheimer disease: In Alzheimer’s Disease (AD) models, morusin inhibits beta-secretase activity, reducing amyloid-beta (Aβ) plaque formation, and impairs tau phosphorylation, which is linked to neurofibrillary tangle formation and neuronal dysfunction.